iBio, Inc.
141 articles about iBio, Inc.
-
iBio, Inc. Adds To iBioModulator Portfolio And Product Pipeline
2/4/2015
-
Warren Ribley Named President & CEO Of iBio, Inc. And The iBIO Institute
1/7/2015
-
iBio, Inc. Provides Updates On Its IBIO-CFB03 Fibrosis Drug Candidate And Other Activities For The 2014 Annual Shareholders Meeting
12/12/2014
-
iBio, Inc. Grants Caliber Biotherapeutics License For Production Of Antibodies Targeting Ebola
11/10/2014
-
iBio, Inc. Expands Exclusive Product Collaboration With Novici Biotech
10/22/2014
-
iBio, Inc. Responds To Inquiries About Its Role In Emergency Response To Ebola Virus Disease Outbreak
10/17/2014
-
iBio, Inc. Reports On Filing Of 2014 Annual Report
10/6/2014
-
Dr. Thomas A. Medsger Jr. Joins iBio, Inc. Clinical Advisory Board
9/3/2014
-
iBio, Inc. Receives European Patent Allowances For Protein Expression Technology
8/28/2014
-
iBio, Inc. Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital
8/26/2014
-
iBio, Inc. Appoints Another IPF Expert, Dr. J. Terrill Huggins, To Clinical Advisory Board
8/1/2014
-
iBio, Inc. Appoints Dr. Richard M. Silver To Clinical Advisory Board
7/21/2014
-
iBio, Inc. Appoints Dr. Timothy Blackwell To New Clinical Advisory Board
7/16/2014
-
iBio, Inc. Expands Commercial Collaboration With Bio-Manguinhos And Fraunhofer USA Center for Molecular Biotechnology
6/17/2014
-
iBio, Inc. Expands IP Protection Of Biotherapeutic Product For Treatment Of Fibrosis
6/10/2014
-
iBio, Inc. European Patent On iBioModulator Technology Emerges From Opposition Period
6/5/2014
-
iBio, Inc. Receives Patent Allowance In China For Fusion Protein Compositions And Technology
4/24/2014
-
iBio, Inc. Receives Patent Allowances For Pandemic Influenza Therapeutics
3/27/2014
-
iBio, Inc. To Present At The 26th Annual ROTH Conference On March 10, 2014
3/5/2014
-
Phase 1 Clinical Trial Begins For Malaria Vaccine Candidate Based On iBio, Inc.'s Proprietary Technology
2/10/2014